Replies to post #228506 on Biotech Values

[DewDiligence]

MRK’s women’s-health/branded-generics/biosimilars spin-off will be called…Organon!

The original Organon was a subsidiary of Akzo Nobel that Schering-Plough acquired thirteen years ago (#msg-17791687).

[DewDiligence]

Barron’s likes MRK—for both valuation and COVID-19 opportunity:

#msg-157648512

[DewDiligence]

MRK will receive a $9M dividend from its OGN spinoff when the separation occurs on 6/2/21. Most of this windfall will likely be used for business development.

Background:
https://www.businesswire.com/news/home/20210503005228/en

[DewDiligence]

MRK completes OGN spinoff:

https://finance.yahoo.com/news/merck-announces-completion-organon-co-104500216.html

In connection with the spinoff, Merck received a distribution from Organon of approximately $9 billion.

Some of this money will presumably be used for M&A.